Machina Capital S.A.S. Biogen Inc. Transaction History

Machina Capital S.A.S.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $215,689 - $259,633	969 Added 96.23%	1,976 $511,000
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $351,327 - $396,529	-1,387 Reduced 57.94%	1,007 $258,000
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $491,596 - $568,055	1,786 Added 293.75%	2,394 $681,000
Q1 2023 Apr 24, 2023	SELL	$256.56 - $292.34 $74,915 - $85,363	-292 Reduced 32.44%	608 $169,000
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $227,196 - $276,048	900 New	900 $249,000
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $187,727 - $223,243	-1,001 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$193.77 - $244.14 $193,963 - $244,384	1,001 New	1,001 $211,000
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $458,754 - $505,678	-2,092 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $352,370 - $551,148	-1,626 Reduced 43.73%	2,092 $495,000
Q4 2018 Mar 25, 2019	BUY	$278.5 - $352.75 $1.04 Million - $1.31 Million	3,718 New	3,718 $1.12 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.